Product Information

OXCARBAZEPINE 300 MG/5 ML SUSP is a generic product labeled by Bionpharma Inc., priced at $0.1158 per ML under NDC 69452012550. Its NADAC has been published 184 times since May 10, 2023.

FDA first approved this application on Nov 4, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXCARBAZEPINE 300 MG/5 ML SUSP

Oxcarbazepine
$0.1158per ML

Strength

300 mg/5mL

Manufacturer

Bionpharma Inc.

NDC

69452012550

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

OXCARBAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA209652

FDA Approved

11/4/2022

TE Code

AB

On Market Since

2/14/2023

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has been published 184 times since May 10, 2023, and over the history we have for it it has declined 67.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1158 per ML
All-time high$0.3973 (Oct 11, 2023)
All-time low$0.1102 (Sep 23, 2026)
52-week high$0.1512
52-week low$0.1102
Median price$0.2199
Average price$0.2377
Largest weekly change+66.8% (Jun 19, 2024)
Weeks tracked184
Tracking sinceMay 10, 2023

Price History

1W

0.0%

1M

+5.1%

3M

-5.3%

6M

-11.9%

1Y

-26.8%

3Y

-69.7%

5Y

N/A

All

-67.2%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OXCARBAZEPINE 300 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG/5 ML SUSP, manufactured by Bionpharma Inc., is $0.1158 per ML (NDC 69452012550), effective Nov 11, 2026.

How has the price of OXCARBAZEPINE 300 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has declined 67.2%. It has been tracked across 184 weekly CMS publications since May 10, 2023.

What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG/5 ML SUSP?

Since May 10, 2023, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has ranged from a low of $0.1102 (Sep 23, 2026) to a high of $0.3973 (Oct 11, 2023), with a median of $0.2199 per ML.

Are there cheaper alternatives to OXCARBAZEPINE 300 MG/5 ML SUSP?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXCARBAZEPINE 300 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures OXCARBAZEPINE 300 MG/5 ML SUSP?

OXCARBAZEPINE 300 MG/5 ML SUSP (NDC 69452012550) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.